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Abstract.  Diverse cell-surface molecules of the ner- 
vous system play an important  role in speci~ing cell 
interactions during development.  Using a  method de- 
signed to generate mAbs against neural surface mole- 
cules of defined molecular weight,  we have previously 
reported on the surface protein, Bravo, found in the 
developing avian retinotectal system. Bravo is im- 
munologicaUy detected on developing optic fibers in 
the retina,  but absent from distal regions of the same 
fibers in the tectum. 
We have isolated eDNA clones encompassing the 
entire coding region of Bravo, including clones con- 
taining  five alternative sequences of cDNA. These 
putative alternatively spliced sequences encode 
stretches of polypeptide ranging  in length  from 10-93 
amino acids and are predicted to be both extra- and 
intracellular.  The deduced primary  structure of Bravo 
reveals that,  like the cell adhesion molecules (CAMs) 
chicken Ng-CAM and mouse L1, Bravo is composed 
of six Ig-like domains,  five fibronectin type HI repeats, 
a transmembrane  domain, and a  short cytoplasmic re- 
gion.  Recently, the cDNA sequence of a related mole- 
cule, Nr-CAM,  was reported and its possible identity 
with Bravo discussed (Grumet, M., V. Mauro, M.  P. 
Burgoon, G.  E.  Edelman,  and B.  A. Cunningham. 
1991. J.  Cell Biol. 113:1399-1412).  Here we confirm 
this identity and moreover show that Bravo is found on 
Miiller glial processes and end-feet in the developing 
retina.  In contrast to the single polypeptide chain 
structure of Nr-CAM reported previously, we show 
that Bravo has a heterodimer structure composed of an 
ct chain of Mr 140/130 and a/~ chain of 60-80 kD. As 
with L1 and Ng-CAM, the two chains of Bravo are 
generated from an intact polypeptide by cleavage at 
identical locations and conserved sites within all three 
molecules (Ser-Arg/Lys-Arg).  The similar domain 
composition and heterodimer structure,  as well as the 
40%  amino acid sequence identity of these molecules, 
defines them as an evolutionarily related subgroup of 
CAMs. The relationship of Bravo to molecules known 
to be involved in cell adhesion and process outgrowth, 
combined with its pattern of expression and numerous 
potential isoforms, suggests a complex role for this 
molecule in cell interactions during  neural devel- 
opment. 
T 
HE development of a functioning  nervous  system in- 
volves the creation of a complex network of cells and 
cell processes. In vertebrates, this often requires axons 
born in one area to project and form synapses in distant areas 
of the nervous system. The visual system of lower vertebrates 
is particularly well-suited to studies  of patterned neuronal 
projections (Crossland et al., 1975). In general, fibers from 
retinal ganglion cells grow towards the optic fissure, exiting 
the retina as the optic nerve which crosses the chiasm and 
innervates the optic tectum. A topographic map of the retina 
is  formed  on  the  tectum  with  neighboring  retinal  cells 
projecting to neighboring  tectal cells. 
The retinotectal system lends itself well to molecular anal- 
ysis because cells and cell processes in this system interact 
with each other and  with components of the extracellular 
matrix  (ECM) 1 via a wide variety of known molecules. An 
increasing body of primary structure  data has revealed that, 
in general,  these ceU-surface and ECM molecules are "mo- 
saic" proteins (Doolittle,  1985) assembled-presumably by 
exon shuffling-from a number of different structural units 
or domains (see reviews in Bork, 1991). The cadherins,  for 
example, are integral membrane glycoproteins  composed of 
four repeated external domains that promote homophilic cell 
adhesion  in a Ca2§  manner (Takeichi,  1991; In- 
1.  Abbreviations  used in  this paper:  ECM, extracellular  matrix;  FNIII, 
fibronectin  type  HI  homology  repeat;  CAM,  cell  adhesion  molecule; 
N-CAM, neural-CAM: Ng-CAM, neuron-glia CAM; Nr-CAM, Ng-CAM 
related CAM; OFL, optic fiber layer; PCR, polymerase  chain reaction; 
PFA, paraformaldehyde;  RT, room temperature. 
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lax matrix such as collagen, laminin, fibrinogen, fibronectin, 
thrombospondin,  vitronectin,  and  von  Willebrand  factor 
(reviewed in Reichardt and Tomaselli,  1991) also demon- 
strate a mosaic nature- being composed of regions with ex- 
tensive  internal  homology  repeats  and  homologies  with 
other known proteins (Engel,  1991). 
Another important group of cell-surface molecules found 
in the developing nervous system includes several  neural 
cell-surface members of the immunoglobulin superfamily 
collectively  known  as  Ig-CAMs  (Williams  and  Barclay, 
1988;  Salzer and Colman, 1989).  The neural cell adhesion 
molecule (N-CAM) is the most abundant and well-studied of 
the Ig-CAMs, promoting homophilic cell-cell adhesion via 
a  Ca2+-independent  mechanism.  N-CAM  has  been  pro- 
posed to play a  major role in a  variety of developmental 
events including axon-axon adhesion, neuroblast migration, 
stabilization of synaptic junctions, and varied roles in other 
tissues including muscle, kidney, heart, and feathers (Edel- 
man,  1986;  Crossin et al.,  1985;  Chuong et al.,  1985). 
N-CAM is composed of five immunoglobulin-like domains 
and two fibronectin type III homology repeats (FNIIIs). 
Molecules with multiple Ig-domains and FNIIIs define an 
ancient family (older than the divergence of arthropods and 
chordates)  of Ig-CAMs  (Edelman,  1987; Jessell,  1989). 
Many of these molecules have been shown to be involved in 
cell-cell adhesion and axon fasciculation and in the promo- 
tion of neurite outgrowth and cell migration. In addition, the 
restricted pattern of expression of some of these molecules, 
TAG-l, fasciclin II, and neuroglian, suggest they might serve 
as cell or axonal guidance molecules (Dodd et al.,  1988; 
Haxrelson and Goodman, 1988;  Bieber et al.,  1989). 
In an attempt to identify additional members of the Ig- 
CAM family, we generated mAbs specifically against cell- 
surface molecules of the same molecular weight as many of 
these family members,  '~135  kD  (Kayyem et al.,  1992). 
Using this approach we identified not only all of the previ- 
ously identified chicken Ig-CAMs,  but also  a  number of 
other molecules including the novel neural cell-surface mol- 
ecule Bravo (de la Rosa et al.,  1990;  Kayyem, J. F., J. M. 
Roman, E.  J.  de la Rosa,  U.  Schwaxz,  and W. J.  Dreyer. 
1990. J. Neurosci. Abstracts. 16:1010). 
Bravo shows a striking pattern of topological restriction in 
the embryonic chicken retinotectal system (de la Rosa et al., 
1990).  Bravo is present on the retinal portion of optic fibers 
during the period of time when optic fibers axe growing to- 
wards the tectum and seeking their targets, but it is not de- 
tectable on tectal regions of these same optic fibers. Prelimi- 
nary amino acid  sequence  analysis suggested Bravo  is  a 
member of the immunoglobulin superfamily most closely 
related to  mammalian L1  and chicken neuron-glia (Ng)- 
CAM (Moos et al., 1988;  Rathjen et al.,  1987; Burgoon et 
al.,  1991). 
Here we show results from protein analysis and molecular 
cloning of Bravo cDNAs which confirm this relationship to 
the immunoglobulin superfamily and reveal Bravos identity 
with  Ng-CAM  related  CAM  (Nr-CAM)  (Grumet  et  al., 
1991). In contrast to results reported on Nr-CAM, we show 
that Bravo is a heterodimer composed of an a  chain of Mr 
130/140 noncovalently attached to a ~/chain of 60-80 kD. 
A similar heterodimer structure has been proposed for both 
L1  and Ng-CAM  (Burgoon et al.,  1991; Faissner et al., 
1985).  These ct and/~ chains are derived from intact poly- 
peptides by proteolytic cleavage at identical locations and 
conserved sites on each of these molecules. Furthermore, we 
have identified five putative alternatively spliced sequences. 
The nature of the restricted pattern of Bravo expression as 
well as the sequence and structural relationship to L1 and 
Ng-CAM suggests Bravo is involved in fiber contacts and fas- 
ciculation  during  development.  The  possible  controlled 
splicing of alternative cDNA sequences identified here and 
in Grumet et al. (1991) offers the intriguing possibility that 
differential processing  of Bravo  mRNA  significantly in- 
creases the potential functions of this cell-surface molecule. 
Materials and Methods 
Immunohistochemistry 
Eight anti-Bravo mAbs and one anti-Ng-CAM mAb used in these experi- 
ments were generated using a novel method for isolating, fractionating, and 
generating a vigorous murine immune response against tectal surface com- 
ponents of approximately Mr 135 kD (Kayyem et al.,  1992).  Embryonic 
day eight (E8) chick embryos were fixed with paraformaldehyde (PFA) by 
overnight immersion at room temperature (RT) in 4% PFA in 0.1 M sodium 
phosphate buffer (pH 7.0) followed by soaking in 30%  sucrose for 4  h. 
Retinotectal tissue was sliced horizontally into  12-~m sections using a 
freezing microtome, adhered to poly-lysine-coated slides, and allowed to 
air dry overnight at RT. 
Sections were stained using a 1:1,500 dilution of mAb ascites fluid in PBS 
with 10% FCS (Gibco Laboratories, Grand Island, NY) or using undiluted 
culture supernatant fluid for 1 h at RT. Sections were washed three times 
in PBS for 5 rain at RT, followed by a 1-h incubation with fluorescein-labeled 
goat anti-mouse Ig (Cappel Laboratories, Malvern, PA) diluted 1:200  in 
PBS. Sections were washed again as before and post-fixed by incubation 
with 4% PFA in 0.1 M sodium phosphate buffer, pH 7.0, for 2 rain at RT. 
Finally,  stained sections were mounted in glycerol and photographed with 
a Photomicroscope (Carl Zeiss, Oberkochen, Germany). 
Purification of  Antigen by 
Immunoaffinity Chromatography 
Before its immobilization on a column, anti-Bravo mAb 2F12 and anti-Ng- 
CAM mAb 2B8 were purified from mouse ascites by chromatography on 
a CM Afli-G-r  Blue column (Bio-Rad Laboratories, Cambridge, MA), ac- 
cording to the manufacturer's instructions. Purified mAb (10 rag) was bound 
to 3 ml of Alfi-Gel 10 (Bio-Rad Laboratories) by overnight incubation with 
gentle agitation in PBS at 4~  as recommended by the manufacturer. A 
column of  each solid support was pre-run with the various buffers to be used 
for antigen purification (see below). 
Bravo and Ng-CAM proteins were purified from post-hatching day 1 (Pl) 
chicken brains which were first washed three times for 5 rain in 140 mM 
NaC1, 5 mM KC1, 5 mM glucose, 7 mM NaHCO3,  1.5 mM MgSO4, and 
1.5 mM CaC12 with iodoacetamide (2 mg/ml), PMSF (0.2 mg/ml) and soy- 
bean trypsin inhibitor (50/~g/rnl)  added as protease inhibitors. Brains were 
lysed by shaking tissue for 15 min at RT in lysis buffer (3 ml per brain): 
10 mM Hepes, pH 7.5, 140 mM NaCI, 4 mM EDTA, 2.5% NP-40 (Sigma 
Chemical  Co.,  St.  Louis,  MO),  2.5%  zwittergent 3-14  (Calbiochem- 
Behring Corp., San Diego, CA), supplemented with 0.02%  azide and 0.5 
/zl/ml aprotinin in addition to the same protease inhibitors used for washing 
(Updyke and Nicolson, 1984). After centrifugation (50,000 g, 30 rain, 4~ 
the supernate from 200 brains was gravity loaded onto the affinity column 
at a flow rate of '~ 30 ml/h. To remove nonspecifically and weakly bound 
material, the 3-ml column was washed as follows: (a) 50 ml PBS containing 
0.5% NP-40; (b) 20 mi of 20 mM Tris-HCL, pH 8.0, containing 140 mM 
NaC1, 0.5% NP-40 and 0.5% Zwittergent 3-14; (c) 10 ml of 50 mM Tris- 
HCI, pH 8.0, containing 0.5 M NaC1 and 0.5% NP40; and (d) 10 ml of 50 
mM Tris-HC1, pH 9.0, containing 0.5 M NaCI and 0.1% NP-40. The antigen 
was eluted with 12 ml of 50 mM triethanolamine, pH 11.5, containing 150 
mM NaC1 and 0.1% NP-40. Fractions of 1.2 ml were collected in tubes con- 
taining 0.3 mi of 1 M Tris-HC1,  pH 6.7. The fractions were analyzed using 
SDS-PAGE and peak fractions were concentrated in a centricon-30 (And- 
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the column was regenerated by washing with 20 ml of 20 mM Tris-HCl, 
pH 8.0, containing 140 mM NaCI, and 0.025%  azide. 
Protein Analysis 
Purified proteins were separated on SDS-PAGE  (6 or 7.5%  acrylamide) 
using standard methods  (Laemmli,  1970)  and silver stained using the 
method of Ansorge (1985). DTT (75 mM) or iodoacetamide (100 mM) was 
added to the protein samples before analyses by SDS-PAGE to produce 
reducing or nonreducing conditions, respectively.  Molecular weights were 
determined by comparison with molecular weight standard from Bio-Rad 
Laboratories: 200 kD, myosin;  116 kD,/3-galactosidase;  93 kD, phosphory- 
lase B; 66 kD, BSA; and 45 kD, ovalbumin. 
For Western blots, proteins were transferred to Hybond-C (Amersham 
Corp.) using essentially the method of Towbin et al., 1979. After blocking 
sites on the membrane overnight  with 5 % BSA in PBS, the membranes were 
labeled with mAb ascites fluid at a 1/1,000 dilution for 1 h, or with a 1/20 
dilution of the anti-HNK-1 mAb "Anti-Leu 7" from Beckton-Dickinson & 
Co., Mountain View, CA. Reactive proteins were subsequently visualized 
using  standard  biotin/avidin sandwich methods  with  biotinylated goat 
anti-mouse immunoglobniin (Amersham Corp.;  1:200)  and HRP-COnju- 
gated streptavidin (Amersham Corp.; 1:200) visualized with 4-chloronap- 
thol (0.5 mg/ml) and H202 (0.015%) in PBS. 
Amino-terminal and internal protein sequence information was gathered 
using a protein sequenator (model 477A; Applied Biosystems, Foster City, 
CA) with on-line PTH analysis. Antigens (30-200 pmole) were purified by 
affinity chromatography as described above, and subsequently electroblot- 
ted  onto polyvinylidene difluoride (PVDF)  membrane following  SDS- 
PAGE (Matsudaira, 1987). Alternatively,  peptides were generated from the 
affinity purified proteins by treatment with V8 protease (Sigma Chemical 
Co., St.  Louis, MO) overnight at 37~  at a protein/enzyme ratio of 50:1 
(wt/wt), before separation on a C18 (Pharmacia Fine Chemicals, Piseata- 
way, NJ) HPLC column (Faissner et al.,  1985).  Peak fractions were col- 
lected while monitoring absorbance at 215 rim, and then loaded directly 
onto the protein sequenator. 
DNA Cloning and Sequencing 
Total  RNA  was  prepared  from  E7  retina and  from  El7  cerebella  by 
homogenization of tissue in cesium trifluoroaeetic  acid (Carter et al., 1983). 
Poly (A)  + RNA was prepared using oligo (dT) spin columns from Pharma- 
cia Fine Chemicals. eDNA libraries were constructed in hZaplI (Strata- 
gene, La Joila, CA) from the poly (A)+ retinal RNA using the RNAse H 
method (Gubler and Hoffman, 1983) and random oligonucleotides (Pro- 
mega Biotec,  Madison, WI) as primers. A  library was also prepared by 
Stratagene from the poly (A)  + eerebellar RNA using random oligonucleo- 
tides as primers. 
All three libraries were screened with a  mixture of eight anti-Bravo 
mAbs: 2B3, 2F12, 3AI0, ICt0, 3Eli, 3CO, IC4, and IF3 (Young and Davis, 
1983). The mAbs were pooled and diluted in PBS such that each mAb was 
represented at 1/1,000  ~  the concentration of its ascites fluid.  Five puta- 
tively Bravo plaques were identified using HRP-conjngated  anti-mouse Ig. 
Only one of these (from the Stratagene El7 cerebellar poly [A]  + library) 
was  reactive with Bravo  mAbs after plaque purification to homogeneity 
(Maniatis et al.,  1982). 
This clone, Bravo-l,  was subeloned into the plasmid pBluescript using 
an in vivo excision technique as per Stratagene's  instructions. The eDNA 
was partially sequenced from pBInescript using dideoxy sequencing and Se- 
qnenase 2  (United States Biochemical, Cleveland, OH)  (Sanger et al., 
1977), and its identity with Bravo confirmed by comparison with amino acid 
sequence data generated from a Bravo peptide. After EcoRI excision of the 
Bravo-I  insert and subsequent subcloning into Pmob vector (kindly sup- 
plied by Dr. Michael Strathmann, University of California, Berkeley, CA), 
the remainder of Bravoq was sequenced using a transposon based strategy 
(Strathmann et al.,  1991). 
To identify remaining Bravo eDNA sequences, Bravo-1 insert was labeled 
with 32p-dCTP by random oligonucleotide priming (Feinberg and Vogel- 
stein, 1984) and used to screen the cerebellar eDNA library.  Oligonucleo- 
tide primers (Caltech Microehemical Facility,  Pasadena, CA) matching 
either the 5' or the 3' end of the Bravo-1 insert were used in conjunction 
with vector primers (MI3 universal and reverse primers) in PCR reactions 
to determine which of the positive clones contained the most new 5' and 
3' sequences,  respectively.  N1 and C1 were derived in this way (see Fig. 
4 a). 
For sequencing,  NI and C1 were purified to homogeneity and subcloned 
into pBluescript as before.  Synthetic oligonueleotide primers were used in 
both the sense and anti-sense directions to determine the new sequences 
(with some overlap with Brm~l) of these clones. To identify sequences en- 
coding the COOH terminus of Bravo, the 3' end of C1 was amplified and 
labeled by PCR. Using primers spaced 300-bp apart, a band was PeR am- 
plified from C1  DNA  and  gel  purified using standard protocols.  The 
purified fragment was then labeled using the "single-stranded PCR" ~zch- 
nique by amplification through 35 linear cycles with the sense PCR primer 
incorporating 3zP-dCTP as  the  only  source  of  cytosine.  This  single- 
stranded probe was used to screen the cerebellar eDNA library, and positive 
clones were mapped by PCR. Two clones, C2 and C3, encoding alternative 
COOH termini of the protein were identified in this way, and sequenced as 
described above. 
eDNA sequences were compiled using the GCG system software package 
(Devereux  et al.,  1984).  Translated sequences from Bravo and from the 
GenBank database were compared pairwise using the FASTA algorithm 
(Pearson and Lipman,  1988) to determine percent sequence identifies. 
Results 
mAbs raised against E8 tectal surface proteins of •135  kD 
stained retinotectal  tissue sections  in a variety of patterns. 
At least nineteen patterns of reactivity have been identified 
from mAbs of this fusion, including  a group of mAbs we 
originally  called Alpha (using the international  phonetic al- 
phabet).  The Alpha staining  pattern is identical  to that of 
mAbs against  the neural  cell-surface molecule Ng-CAM, 
which is also known as 8D9 and G4 (Grumet and Edelman, 
1984; Lemmon and McLoon, 1986; Rathjen et al.,  1987). 
Immunocross-reactivity  studies  on  purified  antigen,  and 
NH2-terminal  protein  sequencing  revealed  that the Alpha 
antigen  is identical  to Ng-CAM (data not shown). 
Another group of mAbs we call Bravo were found to stain 
tissue in a pattern similar to but distinct from Ng-CAM. In 
contrast to the large number (>100) of Alpha mAbs that were 
generated  in this  fusion, only eight Bravo mAbs were de- 
tected, perhaps reflecting the relative  abundance  or antige- 
nicity of these two molecules.  Three anti-Bravo mAbs (2B3, 
2F12, and 3Ell) were used to characterize the Bravo protein 
and its distribution. 
Distribution of  Antigen 
Anti-Bravo mAbs stain all fiber layers of the retina as soon 
as they are morphologically identifiable,  whereas, Ng-CAM 
staining  in the retina  is primarily confined to the ganglion 
cell fibers  of the optic fiber layer  (OFL) (Rathjen  et al., 
1987). We have previously shown that Bravo (and not Ng- 
CAM) labeling  of optic fibers is restricted along  the axon 
length to the proximal region of the retinal axons and absent 
or dramatically  reduced from distal regions in the tectum (de 
la Rosa et al.,  1990). Outside the retinotectal system, both 
Bravo and Ng-CAM appear simultaneously on fibers emerg- 
ing from the early neural tube, and in the developing cerebel- 
lum, both Ng-CAM and Bravo are found primarily on fibers 
in the external granule cell layer (data not shown). 
In  contrast  to  results  reported previously on Nr-CAM 
(Grumet et al.,  1991), we have found Bravo,  but not Ng- 
CAM, expressed on glial processes in the retina. In the OFL, 
MtUler glial processes and end-feet are lined up in parallel 
rows with bundles of retinal axons running between them to- 
ward the optic fissure. In most immunohistologically stained 
sections, dense labeling of the optic fiber fascicles would ob- 
scure any staining of the glia and their end-feet in the OFL. 
However,  certain  sections  situated  along  rows  of  glial 
Kayyem et al. Bravo  1261 Figure 1. Immunofluorescence staining of chicken retina showing 
labeling of Miiller glial end-feet. A region of a cryostat section of 
an E7.5 retina was found relatively free of optic fiber fascicles. 
Labeling of this region with anti-Bravo mAb 2B3, and FITC-con- 
jugated anti-mouse  Ig reveals intense staining of glial end-feet in 
the OFL, as well as staining of processes in the IPL and ganglion 
cell layer (GCL). 
processes show a clear pattern of Bravo staining indicative 
of the labeling of Miiller glial processes and end-feet (Fig. 
1). Also, the possible labeling of ventricular cell processes 
and end-feet in the tectum has been implicated in the Bravo 
staining of tectal structures in the vicinity of the Stratum op- 
ticum (de la Rosa et al.,  1990). 
Bravo Protein Characterization 
Bravo mAbs were used to immunopurify chicken antigens 
from detergent lysates of E8 and El2 tecta, El7 cerebella and 
post-embryonic day 1 (P1) whole brain using anti-Bravo solid 
supports. The column eluates were analyzed by SDS-PAGE 
and in each case showed a prominent doublet at 14/130 kD, 
as well as a diffusely migrating set of bands centered around 
60 and 80 kD (Fig. 2). Thus, no obvious differences exist in 
the pattern of the SDS gel bands of Bravo isolated from these 
different tissues. 
This pattern of bands on SDS-PAGE is nearly identical to 
the patterns found with mouse L1 (Sadoul et al.,  1988) and 
with chicken Ng-CAM (Rathjen et al.,  1987)-shown here 
using Alpha mAb 1El2 (Fig. 2, lane/). The major compo- 
nents purified by the anti-L1 mAb are a  140-kD band and a 
broad band of '~80 kD.  Ng-CAM  mAbs immunopurify a 
135-kD band and diffuse bands around 80 and 65 kD.  The 
140/130-kD  doublet purified by Bravo rnAbs  (Bravo-140/ 
130)  and the higher molecular weight bands of Ng-CAM 
have faster mobilities under nonreducing conditions than un- 
der reducing conditions (Fig. 2), implying that these mole- 
cules are stabilized by internal disulphide bridges. This ap- 
parent molecular weight shift has been described for L1 and 
NILE, the rat L1 equivalent, and suggests that intrachain di- 
sulphide bonds, typical of those characteristic of immuno- 
Figure 2. Ng-CAM and Bravo proteins resolved by SDS-PAGE. Im- 
munoaflinity isolates  using  anti-NgCAM mAbs  and  anti-Bravo 
mAbs were separated by 7.5 % SDS-PAGE  and visualized by silver 
staining. Ng-CAM protein was treated to reduce disulphide bonds 
(lane 1) or treated to protect these bonds (lane 2); similarly, im- 
munopurified Bravo protein  is shown reduced  (lane 3) and un- 
reduced (lane 4).  Note that the Ng-CAM 135-kD band and the 
Bravo 140/130-kD doublet appear to contain internal disulphide 
bonds that cause lower mobility under reducing conditions. A simi- 
lar effect is seen with the less abundant Ng-CAM 190-kD intact 
polypeptide, but not with the lower molecular weight Ng-CAM or 
Bravo 60-80-kD bands. 
globulin domains, am involved in stabilizing the Bravo pro- 
tein (Prince et al.,  1989). 
Both Ng-CAM and L1 are found predominantly as hetero- 
dimers, an ~  polypeptide chain of ,~140 kD noncovalently 
attached to a smaller ~ chain of "~80 kD (Fig. 2) (Sadoul et 
al., 1988; Burgoon et al.,  1991). The pattern of Bravo bands 
in  Fig.  2  suggests  a  similar  dimer  structure.  Anti-Bravo 
mAbs immunopurify both the 140/130 kD and the 60-80-kD 
Bravo polypeptides, but only the higher molecular weight 
bands  react  with  Bravo  mAbs  on  immunoblots,  arguing 
strongly for the heterodimer structure of Bravo (Fig. 3, a and 
b). This suggests that the immunopurification of the 60-80- 
kD polypeptides is the result of their strong association with 
the 130/140-kD polypeptides, as is the case for L1 and Ng- 
CAM. In the case of L1, the 140- and 80-kD components of 
the major heterodimer structure represent products of pro- 
teolytic processing of  an intact polypeptide chain with an ap- 
parent molecular weight of 200 kD.  Similarly, Ng-CAM is 
synthesized as a 200-kD chain, and subsequently processed 
into the 135-kD oe chain and the 80-kD ~ chain components. 
L1 (Sadoul et al., 1988) and Ng-CAM mAbs (Fig. 2) can be 
used to immunopurify these higher molecular weight intact 
molecules. In contrast, no higher molecular weight proteins 
were immunopurified using  Bravo mAbs.  Nonetheless,  a 
Bravo-reactive band of Mr  190 kD was found by immuno- 
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munoblots of Ng-CAM and 
Bravo.  The  immunoaffinity 
isolates (a,  b,  and  c)  using 
anti-NgCAM  (lane 1)  and 
anti-Bravo (lane 2)  were re- 
solved by 6% SDS-PAGE un- 
der  nonreducing conditions, 
transferred to  nitrocellulose, 
and analyzed  by mAb staining 
with anti-NgCAM (a),  anti- 
Bravo  (b), and  anti-HNK-1 
(c). Proteins solubilized from 
the  tectal  lysate  pellet  (see 
Materials and Methods) were 
resolved by 6%  SDS-PAGE, 
transferred to modified nitro- 
cellulose membrane, and sub- 
jected to mAb analysis with 
anti-Bravo (d). Binding of all 
antibodies was visualized  using 
biotinylated second antibod- 
ies bound to HRP-conjugated 
streptavidin. The positions of 
molecular  weight standards 
(reduced) are shown  to the left 
of each panel. 
blotting components of the tectum insoluble in our lysis 
buffer (Fig. 3 d). Presumably, this Bravo precursor is more 
thoroughly or rapidly processed into the a and/~ chains than 
is the case for L1 and Ng-CAM. 
Immunoblotting of purified Bravo protein also reveals that 
this molecule carries the HNK-1 carbohydrate epitope found 
on several other neural molecules as well. The HNK-1 epi- 
tope is associated with cell-adhesion molecules of the ver- 
tebrate nervous system, and may itself  play a role in adhesion 
(Kunemund et al.,  1988;  Kadmon et al.,  1990).  L1, Ng- 
CAM, myelin-associated glycoprotein (MAG), and N-CAM 
among others, are known to carry this epitope (Cole and 
Schachner, 1987; Kruse et al., 1984).  AS shown in Fig. 3 c, 
it is the  130-140-kD  components of both Bravo and Ng- 
CAM-not the 60-80 kD ones-that carry this epitope, anal- 
ogous to the situation with L1 (Faissner et al.,  1985). 
Isolation of  eDNA Clones 
The  initial identification and  isolation of a  Bravo eDNA 
clone  was  achieved by  screening  an  unamplified kZaplI 
cDNA library prepared using mRNA from El7 chicken cere- 
bella. Eight anti-Bravo mAbs were pooled and used to select 
Bravo-1 which was subsequently plaque purified and found 
to react with four of the eight mAbs. 
After excision of the insert and DNA sequencing, Bravo-1 
was found to encode an open reading frame with neither a 
start methionine nor a stop codon. Therefore, we rescreened 
the cerebellar library with the Bravo-1  insert and isolated 
several clones.  These clones were mapped by PCR using 
specific Bravo-1 primers in conjunction with vector primers 
to determine which clones had inserts containing the greatest 
amount of new sequence data. N1  and C1 were derived in 
this way and contained sequences more NH2- and COOH- 
terminal to Bravo-l, respectively. Another rescreen with C1 
produced C2 and C3 which contained alternative 3' coding 
regions (Fig. 4 a). 
The five overlapping Bravo clones (Bravo-l,  N1, C1, C2, 
and C3) were sequenced, and the amino acid sequences of 
the corresponding polypeptides were deduced. The deduced 
amino acid sequence was then compared to the protein se- 
quence data generated by analyses of immunopurified Bravo 
polypeptides. Microsequencing of the first nineteen residues 
of each component of the purified Bravo  140/130  doublet 
yielded identical sequences for the Bravo c~ chains. Peptide 
sequencing of two proteolytic fragments generated by V8 
protease treatment of purified Bravo  ot chains yielded 35 
residues  of unambiguous amino acid sequence  data,  and 
NH2-terminal sequencing of the 60-80-kD  Bravo B chain 
yielded 35 residues of amino acid sequence information. The 
sequences of these components were found in the translated 
sequence of Bravo cDNAs, with two amino acid residue ex- 
ceptions, which we conclude represent amino acid sequenc- 
ing errors.  These putative sequencing errors excepted, the 
remaining protein data matched the derived sequence ex- 
actly at 87  out of 87  sites (Fig,  5).  We conclude that the 
cDNAs we have identified encode Bravo. 
cDNA Sequence Analysis and Comparison to 
U  and Ng-CAM 
As reported earlier (de la Rosa et al.,  1990),  Bravo is a 
member of the immunoglobulin superfamily with close rela- 
tionship to L1 and Ng-CAM. Another molecule similar to 
Ng-CAM was recently characterized and given the name Nr- 
CAM (Grumet et al.,  1991). The cDNA sequence of Nr- 
CAM contains many regions identical in sequence to Bravo, 
though  several  novel  regions  of alternatively  spliced  se- 
quences exist as well. The cDNA sequence determined by 
Grumet et al. (1991) can be found in the EMBL/GenBank/ 
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Figure 4. Schematic representation of Bravo cDNA clones and sequences of novel alternatively spliced regions. (a) The five eDNA clones 
used to determine the sequence of  Bravo are shown. Sequences absent from one or more clones, suggesting alternative processing of mes- 
senger RNA, are indicated by angled lines, and labeled AS10, AS12, AS93, AS-CYTI, and AS-CYT2. Bravo-I was sequenced in its entirety 
using a transposon based strategy for spreading primer sequences throughout the clone. The remaining clones were sequenced using syn- 
thetic oligonucleotide primers in both sense and anti-sense directions. (b) The eDNA (boxed) and derived protein sequences of novel puta- 
tive alternatively spliced regions AS10, AS12, AS-CYTI, and AS-CYT2 are shown in upper case. Flanking Bravo sequences in lower case 
are shown for positioning. AS12 and AS-CYT1 were found associated with and and abutting alternative sequences AS93 and AS-CYT2, 
respectively. Note that these sequences, and AS-CYT2 as well, terminate with the bases AG and contain tracks of polypyrimidines which 
are associated with intron branch points and 3' intron splice sites, suggesting that these sequences may represent incompletely processed 
mRNA. 
DDBJ under accession number X58482.  Novel sequences 
identified in this laboratory are shown in Fig. 4 b. Here, we 
concentrate on results not shown previously, such as the bet- 
erodimer nature of Bravo and the novel regions of putative 
alternative mRNA splicing. 
A comparison of Bravo amino acid sequence to those in 
the translated Genbank sequence database using the FASTA 
rapid homology search showed that Bravo is most closely 
related to L1 (Moos et al., 1988) and to Ng-CAM 03urgoon 
et al., 1991). The extracellular portion of Bravo encodes six 
immunoglobulin-like domains and alternatively four or five 
FNRIs. The complete protein sequence of  Bravo/Nr-CAM is 
shown aligned with L1 and Ng-CAM in Fig, 5. Bravo cDNAs 
as well as those encoding Nr-CAM show regions of  common 
sequence interrupted by stretches of sequence unique to one 
or more clone but absent from others, presumably resulting 
from alternative processing of mRNA.  For example, be- 
tween the second and third immunoglobulin domains lies a 
stretch of amino acids identified in one Nr-CAM clone and 
not found in any Bravo clones. This presumably alternatively 
spliced sequence encodes 20 amino acids and is given the 
name Alternative Sequence, encoding 20 amino acids (AS20) 
(Figs. 4, 5, and 6). In addition, following the sequence en- 
coding the six Ig domains is a  30-bp stretch of novel se- 
quence found in Bravo clone C1  and N1  but not in either 
Bravo-1 or C2. This sequence, highly hydrophobic in profile 
(Kyte and Doolittle,  1982) encodes ten amino acids (Ala- 
Pro-Pro-Thr-Pro-Ala-Ile-Ile-Tyr-Ala) and is denoted AS10. 
AS10 lies in a region analogous to the hinge region of the 
neural cell adhesion molecule N-CAM (Becker et al., 1989). 
This region has been implicated in cis-interactions of  N-CAM 
with both itself and other membrane molecules such as L1. 
In addition, antibodies against this region disrupt optic fiber 
fascicles and cause misrouting of fibers in the retina (Poller- 
berg, G. E., and W. J. Dreyer, manuscript submitted for pub- 
lication). After this alternatively spliced sequence are five 
FNIII repeats, similar to the repeats found in fibronectin but 
far more closely related to those of the neural CAMs. The 
fifth fibronectin repeat (AS93) (also identified as a putative 
alternatively spliced sequence by Grumet et al.,  1991)  is 
missing  from Bravo clone C2,  as  is AS12,  an  additional 
stretch  of novel  sequence  abutting  the  NH2  terminus  of 
AS93 (Figs. 4, 5, and 6). 
The deduced Bravo sequence and comparison to that of L1 
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Figure 5. Alignment of the complete amino acid sequences of Bravo, Ng-CAM, and L1. The eDNA derived sequence of Bravo is identical 
to that of Nr-CAM except for the identification of the putative alternatively spliced sequences, AS20 uniquely in Nr-CAM (Grumet et 
al., 1991) and AS10, AS12, AS-CYTI, and AS-CY'I2 uniquely here. AS93 was identified in both laboratories.  The Bravo sequence (shown 
missing AS-CYT1 which encodes a stop codon and therefore results in a truncated  Bravo protein) was aligned with L1 and Ng-CAM by 
eye and gaps introduced where appropriate  to maximize identity. Identical residues are boxed. The six immunoglobulin-like domains in 
all three molecules are labeled Ig I-Ig VI with characteristic  cysteines and tryptophans  in bold type. The five FNIII repeats in all three 
molecules are labeled FNIII#1-FNIII#5  and characteristic tryptophans and tyrosines (or phenylalanines) are also in bold type. The location 
of the common proteolytic cleavage site is indicated. The NH~ terminus of the Ng-CAM/~ chain is removed by one amino acid (Gin, sin- 
gle letter amino acid code Q) from this conserved site. Sequences confirmed by protein and peptide sequencing of Bravo are overlined 
with two misidentified amino acid residues indicated at positions 2 and 850. A nonstandard amino acid residue labeled "?" was identified 
at position 861, which is a potential asparagine-linked glycosylation site. The transmembrane  domain in all three molecules is underlined 
with dashed lines. Putative alternatively spliced sequences of Bravo are labeled (e.g., AS20) in bold type and bordered by inverted triangles, 
The sequence found alternatively spliced in rat and human equivalents of L1, and identical to Bravo AS-CY'I2, is bordered by triangles. 
and Ng-CAM suggest a common mechanism for the genera- 
tion of the ot and B chains from an intact polypeptide. The 
third fibronectin repeat of Bravo contains the sequence previ- 
ously identified by amino acid sequencing as the NH2 ter- 
minus of the 60-80-kD B chain of Bravo. As expected from 
the  similarity of Bravo to  L1  and  Ng-CAM,  immediately 
NH2-terminal to this  site  is  a  conserved  series  of amino 
acids culminating in the sequence Ser-Lys-Arg in both L1 
and Bravo, and Ser-Arg-Arg in Ng-CAM, suggesting cleav- 
age at this site in all three molecules by a trypsin-like pro- 
tease. Thus, not only is the heterodimer structure of Bravo 
similar to that of L1 and Ng-CAM, but so is the mechanism 
that generates the c~ and B chains: proteolytic cleavage of an 
intact precursor molecule at the COOH-terminal end of the 
consensus  sequence  Ser-Arg/Lys-Arg. Bravo contains this 
putative consensus sequence tandemly repeated at this con- 
served cleavage site (i.e., Ser-Arg-Arg-Ser-Lys-Arg), which 
may explain the absence of detectable intact Bravo 190-kD 
precursor in normal tissue lysates. 
The deduced Bravo sequence reveals numerous potential 
sites  of  N-linked  glycosylation  (Asn-X-Ser/Thr)  spread 
throughout the extraceUular portion of Bravo. These sites 
number 18 within the Bravo sequence proper, and two within 
the putative alternatively spliced region AS20. The deduced 
Bravo sequence also contains a transmembrane domain and 
a  relatively  short  cytoplasmic domain  much  of which  is 
highly conserved with Ng-CAM and L1 but which has no 
known structural  motif.  Because L1  is phosphorylated in 
vivo, and thought to co-purify with at least one kinase (Faiss- 
ner et al.,  1985; Sadoul et al.,  1989; Schuch et al.,  1989), 
the primary sequence of Bravo was analyzed for potential ki- 
nase substrates (Glass et al.,  1986; Kishimoto et al., 1985; 
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Figure  6.  Topological model  of Bravo  including alternatively 
spliced sequences. The six Ig domains of Bravo are shown as loops 
linked by disulphide (S-S) bonds. The five FNn-ls are shown as 
darkened boxes. The six potential alternatively spliced regions are 
shown by hatched boxes labeled AS20, AS10, AS12, AS93, AS- 
CYT1, and AS-CYT2. Two alternative cytoplasmic domains are 
shown, one terminating within AS-CYT1 and resulting in a trun- 
cated Bravo isoform. Putative asparagine-linked glycosylation sites 
are indicated with circle-and-stick symbols. The oversized circle- 
and-stick symbol within FNIII#3 of the Bravo/~ chain denotes the 
Kuenzel et al.,  1987). Eight potential phosphorylation sites 
are present within the cytoplasmic region where L1 has been 
shown to be phosphorylated. Three of  Bravo's eight potential 
cytoplasmic phosphorylation sites may be conserved: two 
align with sites on L1 (Bravo serines 1,225 and 1,248) and 
an additional one matches with sites on both L1  and Ng- 
CAM (Bravo threonine 1,173). 
The putative alternatively spliced cytoplasmic sequences, 
AS-CYT1 and AS-CYT2, contain no consensus sequence for 
known kinases.  AS-CYT1  produces a  shift of frame that 
results  in  a  stop codon within the  cytoplasmic region of 
Bravo, and AS-CYT2, 12-bp long, inserts the amino acid se- 
quence Arg-Ser-Leu-Glu (RSLE, using the one letter amino 
acid code) into Bravos cytoplasmic domain. This tetrapep- 
tide sequence aligns with the identical sequence in the de- 
rived protein sequence of Ng-CAM  and is found alterna- 
tively spliced in both rat and human L1 (Miura et al.,  1991; 
Kobayashi et al.,  1991). 
Discussion 
We have characterized the Bravo glycoprotein (de la Rosa et 
al.,  1990) and found that it is related in structure and pri- 
mary sequence to the cell-surface adhesion molecules Ng- 
CAM and L1. While the primary structure of Bravo has been 
described under the name Nr-CAM, the structure shown be- 
low differs from the structure previously predicted (Grumet 
et al., 1991), specifically with regard to the apparent molecu- 
lar weight of the Bravo protein, its heterodimer nature and 
the potential diversity of alternatively spliced forms. 
Bravo is composed of two different chains. The ot chain is 
found as a doublet of 140/130 kD, containing the six Ig-like 
domains and two complete and one partial FNIII. The Bravo 
/3 chain contains two complete and one partial FNIII as well 
as the transmembrane spanning domain and COOH-terminal 
cytoplasmic sequences. These two chains are found associ- 
ated by noncovalent interactions, and are generated from an 
intact precursor molecule by proteolytic cleavage following 
the sequence Ser-Lys-Arg with FNIII#3 (Fig. 6). 
In addition to conserved structural features, the molecular 
weight of  Bravo matches that of L1 and Ng-CAM. The appar- 
ent molecular weight as determined by SDS-PAGE of the c~ 
and/3 chains ranges from 190 kD (or chain of 130 kD plus 
/3 chain of 60 kD) to 220 kD (or chain of 140 kD plus/3 chain 
of 80 kD). These apparent molecular weight determinations 
are significantly higher than the predicted molecular weights 
of polypeptides encoded by the cDNA sequences. The pre- 
dicted molecular weight for Bravo lacking any alternatively 
spliced sequences is 127 kD.  The Bravo protein containing 
all four of the extracellular alternatively spliced sequences 
identified has a predicted molecular weight of 142 kD.  The 
difference in these molecular weights from the apparent pro- 
tein values is presumably due largely to glycosylation. Con- 
sistent with this proposal, Bravo carries the HNK-1 carbo- 
hydrate epitope, and its sequence contains twenty potential 
location of a potential glycosylation site confirmed by amino acid 
sequence analysis to contain a nonstandard amino acid residue, 
presumably a glycosylated asparagine. The location of the cleavage 
site within FNIII#3 is indicated by an arrow. The domains involved 
in the noncovalent association of the o~ and/3 chains are not known. 
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Figure 7. Gene tree represent- 
ing  subgroups of  Ig-CAMs 
identified by amino acid se- 
quence  identity  and  domain 
structure.  Protein  sequences 
for each of  the molecules were 
compared pairwise using the 
FASTA program  of Pearson 
and Lipman (1988). A tree of 
relatedness  was  constructed 
with lines branching at posi- 
tions corresponding to percent 
sequence  identity  (+1.5%). 
Models of the three character- 
istic subgroups are shown to 
the  right.  Hypotheses  about 
the relationship among Bravo, 
Ng-CAM, and L1 (shown as a 
"tri-furcation" of the  tree  in 
this  figure) are  included  in 
the text. 
sites for N-linked glycosylation. The determination of the 
Nr-CAM molecular weight on SDS PAGE as only 145 kD 
(Grumet et al.,  1991) presumably results from the absence 
of the 60-80-kD/3 chain in their protein analyses, and the 
subsequent failure to account for the  substantial  increase 
in apparent molecular weight of the polypeptide caused by 
glycosylation. 
The cleavage of the intact chains of L1,  Ng-CAM,  and 
Bravo at identical locations (within FNIU#3)  and at con- 
served sequences (Ser-Arg/Lys-Arg) may suggest these mol- 
ecules are substrates for a common protease. Investigations 
of  the  processing  of pro-albumin  and  parathyroid  pro- 
hormone  and  several  viral  structural  proteins  (Rice  and 
Strauss,  1981) imply the presence in the Golgi apparatus of 
proteases that cleave specifically after two basic amino acids, 
as is found with L1, Ng-CAM, and Bravo. Indeed, the cleav- 
age sites of Bravo and Ng-CAM exactly match proteolytic 
cleavage sites found in alphavirus and flavivirus glycopro- 
teins,  respectively (Strauss  et al.,  1987).  The cleavage at 
such a dibasic site within a FNIII may be a common mecha- 
nism to produce noncovalently associated heterodimers. The 
insulin receptor, a mosaic cell-surface protein that includes 
multiple FNIIIs, is found as a heterodimer generated from 
an intact polypeptide by cleavage following the sequence: 
Ser-Arg-Lys-Arg-Arg,  remarkably  similar  to  Bravo's  Ser- 
Arg-Arg-Ser-Lys-Arg (Ebina et al.,  1985). While the func- 
tion of cleavage at this site and the possibly different roles 
of intact versus heterodimer structures in these molecules 
has not yet been elucidated, it appears in these cases that this 
dibasic site is used for processing of a pre-protein form. 
The similar structures of Bravo, Ng-CAM, and L1, includ- 
ing the proteolytic cleavage site, creates a subgroup of neural 
Ig-superfarnily members.  Pairwise  sequence comparisons 
support such a grouping, as these three molecules (and their 
equivalents) are more closely related to each other than to 
any as yet reported molecules. The results of a pairwise com- 
parison of these and other vertebrate neural molecules are 
shown graphically represented as  a  "gene tree" (Fig.  7). 
Quantitative sequence identity comparisons (shown by the 
left to right position of"branch" points) supported by the ar- 
rangement of conserved domains  among these molecules 
suggest the division of neural Ig-superfamily members into 
three subgroups. N-CAM represents the first subgroup. It is 
characterized by five Ig-like domains and two fibronectin 
type III repeats (Cunningham et al.,  1987;  Santoni et al., 
1987). The next subgroup consists of  two pairs of molecules. 
F3 and Contactin/Fl 1 are thought to be equivalent molecules 
in mouse and chicken, respectively (Gennarini et al., 1989; 
Ranscht et al., 1988; Briimmendorf et al., 1989). Likewise, 
rat TAG-I and chicken axonin-1 are also thought to be equiv- 
alent, although the complete characterization of the axonin-1 
cDNA has not yet been reported (Furley et al.,  1990). The 
layout of these molecules is six Ig domains, four FNIIIs and 
a glycosylphosphatidylinositol  linkage to the membrane. With 
each of these pairs,  the  equivalent molecules are roughly 
80%  identical to each other. 
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and Bravo do not reveal any equivalency among these mole- 
cules. The gene tree in Fig. 7 represents clearly that neither 
Ng-CAM nor Bravo is equivalent to L1 as the "tri-furcation" 
of these three molecules is displaced far to the left (lower 
percent identity) of the bifurcation of the other molecules. 
Mouse L1  is equally related at the level of amino acid se- 
quence identity (40%) to both chicken Ng-CAM and Bravo. 
The application of molecular clocks to related molecules in 
setting  up  phylogenetic  trees  relies  on  the  premise  that 
equivalent  molecules diverge  at a  relatively  constant  rate 
over a given length of time in a particular group of organisms 
(Dayhoff et  al.,  1969).  The  roughly  20%  divergence  of 
N-CAM, TAG-l, and F3 from their chicken equivalent over 
the same amount of time conforms to this premise. The much 
larger disparity (60%) of L1 and Ng-CAM and of L1 and 
Bravo suggests that neither  Ng-CAM nor Bravo is the L1 
equivalent. 
The close relationship of Bravo, Ng-CAM, and L1, espe- 
cially at the level of higher order protein structure, suggests 
their roles may be similar.  LI and Ng-CAM have both been 
implicated in neuron-neuron  adhesion,  axon fasciculation 
and neurite outgrowth (Chang et al.,  1987;  Fischer et al., 
1986;  Grumet  and Edelman,  1988;  Grumet et al.,  1984; 
Lagenaur and Lemmon,  1987; Lemmon et al.,  1989; Stall- 
cup and Beasley,  1985), and the drosophila molecule neu- 
roglian, of a similar structure to the L1 subgroup oflg-CAMs 
discussed  here,  facilitates  cell-cell  adhesion  when  trans- 
fected  into  non-adhesive  cell  lines  (Hortsch  and  Bieber, 
1991).  Therefore, it seems likely that Bravo plays a role in 
neural adhesion and fasciculation. 
This close relationship of Bravo and Ng-CAM suggests the 
possibility that these two molecules interact heterophilically 
(as do L1 and Ng-CAM with the same 40% sequence iden- 
tity) (Lemmon et ai.,  1989). This is consistent with the ob- 
servation that Ng-CAM mediates neuron-glia adhesion via 
heretofore unidentified glial components which may include 
Bravo (Grumet et al.,  1984).  Given the results described 
here, it will be possible to test the role of the different Bravo 
isoforms  in  neuron-neuron  and  neuron-glia  adhesion  by 
means of several new assays (e.g., Hortsch and Bieber, 1991; 
Lee and Lander,  1991).  The restricted distribution of Bravo 
along retinal axons suggests that it might be involved in both 
the strong fasciculation of retinal fibers seen in the retina and 
the reduced fasciculation of these same fibers seen in the tec- 
turn where Bravo is not detected.  The absence or reduced 
levels of Bravo protein on distal axons in the tectum (de la 
Rosa et al., 1990) might play a role in reducing the cohesive- 
ness of retinal axons for each other, allowing less hindered 
target seeking by the growth cones. In addition,  Bravo pro- 
tein found on glial end-feet in the retina (and possibly in the 
tectum) might interact with the retinal axons that track along 
this glial substrate. 
The possibly extensive use of alternative splicing suggests 
a complex and developmentally regulated role for Bravo. In 
analyzing only five clones in this laboratory, five putative al- 
ternatively spliced sequences were identified, not counting 
AS20 identified previously (Grumet et al.,  1991).  Alterna- 
tive splicing of mRNA precursors can provide an important 
mechanism  for  generating  developmentally  programmed 
functional diversity of proteins involved in cell-surface rec- 
ognition (e.g,, Smith et al.,  1989). The specific sequences 
that may be included  or excluded in a particular  isoform 
have,  in  several examples,  been characterized  as  specific 
functional protein domains that contribute to different cell 
adhesion properties (Huhtala et al.,  1990: Komoriya et al., 
1991; Sift et al., 1991; Weller et al., 1991). The programmed 
alternative  splicing  of  FNIIIs,  in  particular,  as  well  as 
numerous  other functional protein  domains  is a  powerful 
mechanism for generating  functional diversity among cell- 
surface  receptors  during  development  (Kimizuka  et  al., 
1991). Therefore, it is interesting to note that both Bravo and 
Nr-CAM cDNA clones have been identified with sequences 
either containing or missing FNIII#5, and that the Bravo pro- 
tein 15 chain shows molecular weight heterogeneity (60-80 
kD) suggestive of the presence of these two isoforms. 
Bravo cDNA clones reveal alternative  sequences within 
the cytoplasmic region  as well.  All alternative  cDNA se- 
quences will require  genomic DNA sequencing to ensure 
that they do not represent cloning artifacts, but in particular 
the sequence of AS-CYT1 suggests the need for further anal- 
ysis,  as it encodes a  frameshift resulting  in a  stop codon 
within the highly conserved cytoplasmic domain.  In addi- 
tion,  AS-CYT1  and  AS-CYT2  both  show  similarity  to  3' 
regions of introns, including potential polypyrimidine tracks 
and termination with the nucleotide sequence AG (Smith et 
al., 1989). Olne or both of these sequences might, therefore, 
represent  incompletely  processed  mRNA.  On  the  other 
hand, in support of the notion that AS-CYT2 is not an artifact 
of cloning but actually encodes a functional Bravo variant, 
it is important to note that both human and rat versions of 
L1  contain  alternatively  spliced  sequences corresponding 
exactly to the tetrapeptide encoded by AS-CYT2, Arg-Ser- 
Leu-Glu.  Furthermore,  L1 from rat shows a tissue-specific 
regulation of this alternative cytoplasmic sequence: the iso- 
form missing this sequence is predominantly  expressed in 
the brain, while the RSLE isoform is found in the peripheral 
nervous system (Miura et al.,  1991).  Investigations  of the 
distribution  of Bravo polypeptides (specifically of the iso- 
forms containing or missing AS-CYT2) might reveal a simi- 
lar spatial restriction and suggest some roles for alternative 
splicing in this region, possibly involving alterations of inter- 
actions with cytoplasmic or cytoskeletal proteins critical for 
influencing neurite outgrowth and cell migration. 
The large number of domains and alternatively spliced se- 
quences (both extra-  and intracellular)  suggests numerous 
diverse functions for Bravo proteins. In the developing ner- 
vous system, just as in the immune system, it appears that 
a number of molecules are generated by RNA or DNA splic- 
ing to provide functional diversity among molecules contain- 
ing Ig domains. 
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